AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling. - Zähringer A; Morgado I; Erny D; Ingelfinger F; Gawron J; Chatterjee S; Wenger V; Schmidt D; Schwöbel L; Adams RC; Langenbach M; Hartmann A; et al. (Blood advances, 2025)